1985
DOI: 10.1097/00006254-198510000-00022
|View full text |Cite
|
Sign up to set email alerts
|

Surgical and Pathologic Complications Associated with Peritoneovenous Shunts in Management of Malignant Ascites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1988
1988
1988
1988

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…However, the fluid usually reaccumulates rapidly, and aspirations provide only temporary relief. The use of peritoneovenous shunting for malignant ascites has been widely described.4,6,8-' 1~' [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] Malignant ascites has also been treated by intraperitoneal instillation of radioactive colloids A u '~~ P32) or chemotherapeutic agents (tetracycline, bleomycin, Adriamycin [Adria Laboratories, Columbus, OH], Nitrogen mustard, or cisplatin). Although it has been reported that these modalities yield response rates of 35% to 4070,~ they have most often been used as alternatives to peritoneovenous shunting.…”
mentioning
confidence: 99%
“…However, the fluid usually reaccumulates rapidly, and aspirations provide only temporary relief. The use of peritoneovenous shunting for malignant ascites has been widely described.4,6,8-' 1~' [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] Malignant ascites has also been treated by intraperitoneal instillation of radioactive colloids A u '~~ P32) or chemotherapeutic agents (tetracycline, bleomycin, Adriamycin [Adria Laboratories, Columbus, OH], Nitrogen mustard, or cisplatin). Although it has been reported that these modalities yield response rates of 35% to 4070,~ they have most often been used as alternatives to peritoneovenous shunting.…”
mentioning
confidence: 99%